ins018_055
Small moleculeexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2021 (NCT05154240)
Timeline
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05975983 | Phase 2 | Dec 15, 2023 | InSilico Medicine Hong Kong Limited |
| NCT05938920 | Phase 2 | Jun 19, 2023 | InSilico Medicine Hong Kong Limited |
| NCT05154240 | Phase 1 | Dec 1, 2021 | InSilico Medicine Hong Kong Limited, New Zealand Clinical Research |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| InSilico Medicine Hong Kong Limited | For profit | 3 | 3 | 2 | 2021 |
| New Zealand Clinical Research | For profit | 1 | 0 | 1 | 2021 |
2 organizations
Page 1 / 1